ロード中...
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
Cardiac amyloidosis is a restrictive cardiomyopathy that results from the deposition of misfolded light chain or transthyretin proteins, most commonly, in cardiac tissue. Traditionally, treatment options for light chain (AL) and transthyretin (ATTR) amyloidosis have been limited. However, there are...
保存先:
| 出版年: | JACC Basic Transl Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609907/ https://ncbi.nlm.nih.gov/pubmed/31312767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2019.02.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|